Functional muscarinic receptor predominance may exist in some patients with affective disorders. This functional imbalance between various neurotransmitters may be manifested in depressed mood, elevated hypothalamic pituitary activity, and sleep abnormalities. We have tried two different approaches to test this hypothesis since this grant was originally funded. In the first, we used the Cholinergic REM Induction Test (CRIT), which measures the time to induce REM sleep following administration of arecoline (a muscarinic agonist) during the second NREM sleep period of the night. Our data to this time partially support our earlier findings that patients with affective disorder respond significantly faster than controls. In the second approach, we attempted to replicate the report of Nadi et al (1984) that patients with affective disorders have greater numbers of muscarinic receptors on skin fibroblasts than controls. We were unable, however, to confirm this report, and, partially as a result, Nadi's group has retracted the claim. Since the sleep abnormalities of depression (such as short REM latency, elevated REM density) may reflect central muscarinic over-activity, we propose four new studies which are intended to clarify the relationship between central cholinergic mechanisms, the basic physiological control of normal sleep, and possible pathophysiological sleep mechanisms in patients with major depressive disorders: (1) A Cholinergic Antagonist Challenge Strategy, comparing the sleep, mood, and neuroendocrine response of depressed patients and normal controls to bedtime administration of scopolamine for three nights, (2) A Cholinergic Agonist Challenge Strategy, comparing the REM sleep inducing properties of two different muscarinic agonists, arecoline and RS-86, in depressed and control subjects, (3) a basic neuroanatomical study of the cholinergic afferents to the medical pontine reticular formation, which appear to be crucial for initiating and maintaining REM sleep, and (4) a study of the sleep profile and brainstem muscarinic receptors of a genetic strain of rats (the Flinders Sensitive Line, developed by David Overstreet, Ph.D.) which have elevated numbers of muscarinic receptors in forebrain and which may be an animal model of depression.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Research Project (R01)
Project #
5R01MH038738-06
Application #
3376856
Study Section
Psychopathology and Clinical Biology Research Review Committee (PCB)
Project Start
1984-04-01
Project End
1990-03-31
Budget Start
1989-04-01
Budget End
1990-03-31
Support Year
6
Fiscal Year
1989
Total Cost
Indirect Cost
Name
University of California San Diego
Department
Type
Schools of Medicine
DUNS #
077758407
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Landolt, Hans-Peter; Kelsoe, John R; Rapaport, Marc H et al. (2003) Rapid tryptophan depletion reverses phenelzine-induced suppression of REM sleep. J Sleep Res 12:13-8
Landolt, Hans-Peter; Gillin, J Christian (2002) Different effects of phenelzine treatment on EEG topography in waking and sleep in depressed patients. Neuropsychopharmacology 27:462-9
Landolt, H P; Raimo, E B; Schnierow, B J et al. (2001) Sleep and sleep electroencephalogram in depressed patients treated with phenelzine. Arch Gen Psychiatry 58:268-76
Landolt, H P; Gillin, J C (2001) Sleep abnormalities during abstinence in alcohol-dependent patients. Aetiology and management. CNS Drugs 15:413-25
Landolt, H P; de Boer, L P (2001) Effect of chronic phenelzine treatment on REM sleep: report of three patients. Neuropsychopharmacology 25:S63-7
Gottschalk, L A; Fronczek, J; Abel, L et al. (2001) The cerebral neurobiology of anxiety, anxiety displacement, and anxiety denial. Psychother Psychosom 70:17-24
Drummond, S P; Gillin, J C; Smith, T L et al. (1998) The sleep of abstinent pure primary alcoholic patients: natural course and relationship to relapse. Alcohol Clin Exp Res 22:1796-802
Dow, B M; Kelsoe Jr, J R; Gillin, J C (1996) Sleep and dreams in Vietnam PTSD and depression. Biol Psychiatry 39:42-50
Gillin, J C; Buchsbaum, M S; Valladares-Neto, D C et al. (1996) Effects of zolpidem on local cerebral glucose metabolism during non-REM sleep in normal volunteers: a positron emission tomography study. Neuropsychopharmacology 15:302-13
Seifritz, E; Moore, P; Trachsel, L et al. (1996) The 5-HT1A agonist ipsapirone enhances EEG slow wave activity in human sleep and produces a power spectrum similar to 5-HT2 blockade. Neurosci Lett 209:41-4

Showing the most recent 10 out of 51 publications